- Home
- HCWC vs CDIO Comparison
HCWC vs CDIO Comparison
Compare HCWC & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWC
- CDIO
- Stock Information
- Founded
- HCWC N/A
- CDIO 2017
- Country
- HCWC
- CDIO United States
- Employees
- HCWC N/A
- CDIO N/A
- Industry
- HCWC
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- HCWC
- CDIO Health Care
- Exchange
- HCWC NYSE
- CDIO Nasdaq
- Market Cap
- HCWC 11.8M
- CDIO 12.3M
- IPO Year
- HCWC N/A
- CDIO N/A
- Fundamental
- Price
- HCWC $0.83
- CDIO $0.90
- Analyst Decision
- HCWC
- CDIO Buy
- Analyst Count
- HCWC 0
- CDIO 1
- Target Price
- HCWC N/A
- CDIO $2.00
- AVG Volume (30 Days)
- HCWC N/A
- CDIO 12.3M
- Earning Date
- HCWC N/A
- CDIO 11-13-2024
- Dividend Yield
- HCWC N/A
- CDIO N/A
- EPS Growth
- HCWC N/A
- CDIO N/A
- EPS
- HCWC N/A
- CDIO N/A
- Revenue
- HCWC N/A
- CDIO $35,688.00
- Revenue This Year
- HCWC N/A
- CDIO $2,093.61
- Revenue Next Year
- HCWC N/A
- CDIO $43.05
- P/E Ratio
- HCWC N/A
- CDIO N/A
- Revenue Growth
- HCWC N/A
- CDIO 180.90
- 52 Week Low
- HCWC N/A
- CDIO $0.19
- 52 Week High
- HCWC N/A
- CDIO $3.56
- Technical
- Relative Strength Index (RSI)
- HCWC N/A
- CDIO 58.19
- Support Level
- HCWC N/A
- CDIO $0.99
- Resistance Level
- HCWC N/A
- CDIO $1.77
- Average True Range (ATR)
- HCWC 0.00
- CDIO 0.27
- MACD
- HCWC 0.00
- CDIO 0.04
- Stochastic Oscillator
- HCWC 0.00
- CDIO 41.73
About HCWC HEALTHY CHOICE WELLNESS CORP
Healthy Choice Wellness Corp is a company engaged in providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The company has one reportable segment which is natural and organic retail stores.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.